Results 231 to 240 of about 61,570 (310)

Advances in Techniques for the Structure and Functional Optimization of Therapeutic Monoclonal Antibodies. [PDF]

Biomedicines
He C, Huang W, Wu X, Xia H.
europepmc   +1 more source

Targeting cancer expressed EGFR with a humanized monoclonal antibody. [PDF]

Sci Rep
Costa TGF, Sarnovsky R, Zhan J, Maslanka CA, Obiorah I, Xia D, FitzGerald D, Antignani A.   +7 more
europepmc   +1 more source

Neoadjuvant Atezolizumab and Chemotherapy for Non‐Squamous Non‐Small Cell Lung Cancer: Efficacy and Safety Results of an Open‐Label, Single‐Arm, Phase II Trial

International Journal of Cancer, EarlyView.
Surgery plus chemotherapy is a well‐established treatment protocol for resectable, locally advanced non‐small cell lung cancer (NSCLC). Nonetheless, survival gains remain limited, emphasizing the need for more effective treatments. Here, the authors evaluated a novel approach using a neoadjuvant immunotherapy‐chemotherapy regimen consisting of ...
Benedikt Niedermaier, Tilmann Bochtler, Florian Eichhorn, Raffaella Griffo, Laura V. Klotz, Michael Allgäuer, Albrecht Stenzinger, Helge Bischoff, Marc A. Schneider, Petros Christopoulos, Uwe Haberkorn, Claus Peter Heussel, Inka Zoernig, Felix J. F. Herth, Michael Thomas, Alexander Rölle, Hauke Winter, Axel Benner, Dirk Jaeger, Martin E. Eichhorn   +19 more
wiley   +1 more source

Establishment of a humanized mouse model of pulmonary fibrosis for advancing drug validation strategies. [PDF]

Sci Rep
Hasan MN, Chae Y, Lee SY, Kang YM.
europepmc   +1 more source

GOODS-AWARDS IN THE PROCESS OF SALES PROMOTION [PDF]

, 2014
Kras’ko, A., Kruhlenko, L., Mel’nikova, I., Yelizarova, K.   +3 more
core  

How Does Vulnerability Framing by Microfinance Institutions Leverage Funding Success in Crowdfunding?

International Journal of Finance &Economics, EarlyView.
ABSTRACT This study draws on framing theory to investigate how microfinance institutions (MFIs) strategically construct a vulnerability‐oriented organisational identity and how this framing influences their funding decisions during the pre‐campaign phase of prosocial crowdfunding.
Ana Paula Matias Gama, Ricardo Emanuel‐Correia, Fábio Duarte, Mário Augusto   +3 more
wiley   +1 more source

Person-centered practice in the Portuguese healthcare system: A documentary study. [PDF]

PLoS One
Vareta D, Santana E, Oliveira C, Baixinho C, Ventura F.   +4 more
europepmc   +1 more source

Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum‐resistant ovarian cancer: Phase I expansion results

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective In the dose‐escalation part of Study 101, which included multiple tumor types, objective responses were observed in 10 of 22 patients across multiple dose levels of farletuzumab ecteribulin (FZEC). We explored the safety/antitumor activity of FZEC in patients with platinum‐resistant ovarian cancer (PROC) from the Study 101 expansion ...
Kan Yonemori, Mayu Yunokawa, Koji Matsumoto, Kazuhiro Takehara, Kosei Hasegawa, Yasuyuki Hirashima, Hidenori Kato, Hiroki Ikezawa, Yohei Otake, Wataru Yusa, Takuma Miura, Shin Nishio   +11 more
wiley   +1 more source

SITA: Predicting site-specific immunogenicity for therapeutic antibodies. [PDF]

J Pharm Anal
Cun Y, Ding H, Mao T, Wang Y, Wang C, Li J, Li Z, Hu M, Cao Z, Qiu T.   +9 more
europepmc   +1 more source

Respiratory Syncytial Virus Under the Lens of Structure: From Prefusion Stabilization to Next‐Generation Immunotherapies

iNew Medicine, EarlyView.
This illustration integrates key concepts covered in the review, including high‐risk populations, viral structure, host entry factors, the replication cycle, and licensed antibody‐based prevention strategies. ABSTRACT Respiratory syncytial virus (RSV) is a negative‐sense RNA virus belonging to the genus Orthopneumovirus within the family Pneumoviridae.
Zekai Cheng, Qianqian Wang, Jiachen Zhang, Sandra Chiu   +3 more
wiley   +1 more source